Stock listing

NASDAQ:BNTC Benitec Biopharma Inc. Stock

Home listing (NASDAQ) of Benitec Biopharma Inc.

Follow Benitec Biopharma Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:BNTC

$7.92 USD -0.35 (-4.3%)

Close on Nov 20, 2026

Past year -39.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$7.75 – $8.16 USDNov 20, 2026
Volume
268,684 sharesNov 20, 2026
Market cap
$276.1M USDAt the close on Nov 20, 2026 · price × 34.89M shares outstanding
52-week range
$7.75 – $14.39 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$1.77M USDMedian day 149,010 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Benitec Biopharma Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:BNTC · Home$7.915 USD-0.355 (-4.3%)268,684$8.00$8.163$7.75$8.27Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:BNTC · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$7.915-0.355-4.3%$8.00$8.163$7.75268,684
$8.27+0.12+1.5%$8.14$8.51$8.12128,831
$8.15-0.39-4.6%$8.58$8.63$8.00175,453
$8.54-0.50-5.5%$9.06$9.298$8.51133,358
$9.04-0.05-0.6%$9.17$9.30$8.69144,689
$9.09-0.38-4.0%$9.39$9.39$8.80231,626
$9.47+0.19+2.0%$9.42$9.59$9.20120,637
$9.28-0.59-6.0%$9.86$10.01$9.24105,713
$9.87+0.33+3.5%$9.68$10.22$9.29432,910
$9.54+0.90+10.4%$8.65$9.56$8.555120,361
$8.64-0.64-6.9%$9.32$9.37$8.62311,109
$9.28+0.88+10.5%$8.67$9.39$8.67298,141
$8.40-0.09-1.1%$8.58$8.89$8.305105,817
$8.49-0.25-2.9%$8.81$8.94$8.24240,632
$8.74-0.09-1.0%$8.80$8.93$8.429135,485
$8.83+0.03+0.3%$8.85$9.11$8.73162,538
$8.80+0.12+1.4%$8.58$8.91$8.19238,599
$8.68+0.09+1.0%$8.60$8.849$8.52156,893
$8.59-0.06-0.7%$8.71$8.80$8.5498,628
$8.65-0.17-1.9%$8.91$8.91$8.53158,391
$8.82+0.32+3.8%$8.47$8.85$8.21149,010
$8.50-0.54-6.0%$9.05$9.22$8.40171,850
$9.04+0.68+8.1%$8.35$9.29$8.32347,596
$8.36+0.25+3.1%$8.13$8.618$8.00194,120
$8.11-0.35-4.1%$8.47$8.47$8.06158,600
$8.46+0.17+2.1%$8.37$8.758$8.34153,700
$8.29-0.34-3.9%$8.52$9.07$8.25162,500
$8.63-0.44-4.9%$9.08$9.08$8.51151,400
$9.07+0.20+2.3%$8.90$9.25$8.75200,900
$8.87+0.12+1.4%$8.72$9.03$8.7173,000
$8.75-0.24-2.7%$8.86$8.97$8.61234,900
$8.99-0.01-0.1%$8.81$9.27$8.80190,100
$9.00-0.23-2.5%$9.32$9.565$8.62217,200
$9.23+0.25+2.8%$9.00$9.99$8.52584,200
$8.98-0.60-6.3%$9.71$9.876$8.92135,100
$9.58-0.42-4.2%$9.94$10.17$9.465103,100
$10.00+0.25+2.6%$9.83$10.13$9.64146,000
$9.75-0.27-2.7%$10.17$10.17$9.65111,000
$10.02+0.43+4.5%$9.57$10.04$9.31152,800
$9.59-0.05-0.5%$9.70$9.80$9.306107,000
$9.64-0.19-1.9%$9.74$10.41$9.255196,700
$9.83-1.12-10.2%$10.92$11.32$9.49644,200
$10.95+0.07+0.6%$10.97$11.37$10.6188,900
$10.88-0.14-1.3%$11.12$11.14$10.74121,900
$11.02-0.34-3.0%$11.37$11.62$10.86423,000
$11.36+0.32+2.9%$11.27$11.55$11.1591,300
$11.04-0.01-0.1%$11.09$11.45$10.89138,800
$11.05-1.03-8.5%$12.11$12.37$10.96263,400
$12.08-0.11-0.9%$12.24$12.42$12.01106,400
$12.19-0.03-0.2%$12.38$12.51$12.1288,600
$12.22-0.23-1.8%$12.31$12.47$12.0094,600
$12.45-0.275-2.2%$12.68$13.00$12.2270,000
$12.73+0.045+0.4%$12.55$13.00$12.51102,200
$12.68+0.24+1.9%$12.33$12.83$12.3345,000
$12.44-0.44-3.4%$12.93$13.28$12.2462,600
$12.88+0.57+4.6%$12.36$13.19$12.25191,400
$12.31+0.14+1.2%$12.12$12.43$11.8078,300
$12.17-0.30-2.4%$12.37$12.57$12.0160,800
$12.47-0.20-1.6%$12.60$12.76$11.71103,200
$12.67-0.21-1.6%$13.20$13.21$12.60103,200
$12.88-0.14-1.1%$13.02$13.02$12.6564,600
$13.02+0.31+2.4%$12.79$13.35$12.76255,000
$12.71-0.77-5.7%$13.53$13.64$12.47122,500
$13.48+0.47+3.6%$13.14$13.98$13.03160,100
$13.01-0.37-2.8%$13.27$13.27$12.37426,800

Splits

4 splits since 2015 · NASDAQ:BNTC · every price before a split is adjusted for it

DayRatioWhat
1-for-17Consolidation
2-for-3Consolidation
1-for-10Consolidation
1-for-4Consolidation
Ticker
NASDAQ:BNTC
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Benitec Biopharma Inc. news

Benitec Biopharma Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
13 in the last 12 months · 85 in all · newest Nov 13, 2026 · oldest 2019
Decks
45 decks · latest May 15, 2026

Where Benitec Biopharma Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:BNTC · Home listing · This pageNASDAQUnited StatesUSD
BOATS:BNTCBOATSUnited StatesUSD

Valuation

Price/book 1.6× against a median of 3.6×: 3rd lowest of 7 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$99.78M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
1.6×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.46

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Benitec Biopharma Inc. · NASDAQ:BNTCUS$276.1MUS$99.78Mn/an/an/a1.6×n/a0.0×1.46
TRex Bio, Inc. · NASDAQ:TRXBUS$283.1MUS$205.0Mn/an/an/an/an/an/an/a
Greenwich LifeSciences, Inc. · NASDAQ:GLSIUS$282.6MUS$276.7Mn/an/an/an/an/an/a2.80
Precision BioSciences, Inc. · NASDAQ:DTILUS$282.5MUS$228.3Mn/a5.1×n/a5.5×−85.6%0.5×0.30
AP Biosciences, Inc. · TPEX:6945US$282.3MUS$215.7Mn/an/an/a4.0×n/a0.0×n/a
Fulcrum Therapeutics, Inc. · NASDAQ:FULCUS$281.8M−US$17.87Mn/an/an/a0.9×n/a0.0×0.42
Circio Holding ASA · OSL:CRNAUS$281.1MUS$225.9Mn/an/an/a5.3×n/a0.0×n/a
Relmada Therapeutics, Inc. · NASDAQ:RLMDUS$279.5MUS$77.42Mn/an/an/a1.4×n/a0.0×1.57
Galectin Therapeutics Inc. · NASDAQ:GALTUS$271.4MUS$293.0Mn/an/an/an/an/an/a1.20
Vicore Pharma Holding AB · OMXSTO:VICOUS$271.1MUS$182.5Mn/a467×n/a3.3×n/a0.0×n/a
Agenus Inc. · NASDAQ:AGENUS$270.1MUS$218.3M9.2×1.6×4.0×n/a22.0%n/a1.80
Median of the othersUS$281.5MUS$217.0M9.2×5.1×4.0×3.6×−31.8%0.0×1.39

Forecasts

6 strong buy · 2 buy · Analysts' consensus from EODHD, read Nov 15, 2026. Not 6ix's view and not investment advice.

Price target
23.32 USD · Analysts' mean
EPS, year to Jun 2027
-1.11 · 3 analysts

Team and board

Officers

OfficerRole
Jerel BanksChief Executive Officer & Chairman of the Board
Megan BostonChief Financial Officer & Director
Sophie MukadamChief Operating Officer

Board

DirectorRole
Jerel BanksChief Executive Officer & Chairman of the Board
David FriedmanDirector
Edward SmithDirector
J. Kevin BuchiDirector
Kishen MehtaDirector
Megan BostonChief Financial Officer & Director
Peter FrancisDirector
Sharon MatesDirector

Events

QuarterResultsShare move
Q1 2027Nov 13, 2026 · Before open−0.6%
Q4 2026Sep 14, 2026 · After close−8.5%
Q3 2026May 14, 2026 · Before open+1.7%
Q2 2026Feb 12, 2026 · Before open−2.7%
Q1 2026Nov 14, 2025+2.9%
Q4 2025Sep 22, 2025 · After close−2.1%
Q3 2025May 14, 2025 · Before open+3.0%
Q2 2025Feb 14, 2025 · Before open+16.0%
Q1 2025Nov 14, 2024 · After close+2.7%
Q4 2024Sep 19, 2024 · Before open+3.2%
All 20 quarters
QuarterResultsShare move
Q3 2024May 13, 2024 · Before open−12.2%
Q2 2024Feb 13, 2024 · Before open+0.0%
Q1 2024Nov 13, 2023 · Before open+1.2%
Q4 2023Sep 21, 2023 · Before open+0.3%
Q3 2023May 15, 2023 · Before open+0.9%
Q2 2023Feb 13, 2023 · Before open0.0%
Q1 2023Nov 10, 2022 · Before open+5.4%
Q4 2022Sep 2, 2022 · Before open−3.5%
Q3 2022May 16, 2022 · Before open−8.8%
Q2 2022Feb 14, 2022 · Before open−4.8%

Open Events

Decks

DeckKindSlidesDate
American Society of Cell & Gene Therapy 2026Conference20 slidesMay 15, 2026
Investor Presentation (January 2026)Investor deck43 slidesJanuary 2026
Corporate Update (November 2025)Corporate update31 slidesNov 3, 2025
Investor Presentation (September 2025)Investor deck34 slidesSeptember 2025
Technical Presentation (March 2025)Technical31 slidesMar 19, 2025
Investor Presentation (March 2025)Investor deck41 slidesMarch 2025
Technical Presentation (October 2024)Technical50 slidesOct 14, 2024
Technical Presentation (July 2024)Technical6 slidesJul 15, 2024
Investor Day (April 2024)Investor day71 slidesApr 18, 2024
Investor Day (April 2024)Investor day71 slidesApr 17, 2024
All 45 decks
DeckKindSlidesDate
Investor Presentation (January 2024)Investor deck23 slidesJanuary 2024
Investor Presentation (July 2023)Investor deck28 slidesJuly 2023
Investor Presentation (January 2023)Investor deck28 slidesJanuary 2023
Investor Presentation (June 2022)Investor deck28 slidesJune 2022
Investor Presentation (September 2021)Investor deck39 slidesSeptember 2021
Technical Presentation (February 2021)Technical27 slidesFeb 24, 2021
Technical Presentation (February 2021)Technical27 slidesFebruary 2021
Investor Presentation (September 2020)Investor deck42 slidesSeptember 2020
Investor Presentation (April 2020)Investor deck42 slidesApril 2020
Shareholder Meeting (November 2019)Shareholder meeting42 slidesNov 29, 2019
Ladenburg Thalmann Healthcare Conference 2019Conference39 slidesSep 24, 2019
Investor Presentation (September 2019)Investor deck40 slidesSeptember 2019
Ladenburg Thalmann Healthcare Conference 2019Conference39 slidesSeptember 2019
Technical Presentation (November 2018)Technical19 slidesNov 11, 2018
Shareholder Meeting (November 2018)Shareholder meeting17 slidesNov 8, 2018
BIO 2018Conference42 slidesMay 28, 2018
30th Annual Roth Conference (March 2018)Conference35 slidesMar 13, 2018
Biotech Showcase 2018Conference35 slidesJan 8, 2018
2017 ESGCT ConferenceConference17 slidesOct 18, 2017
Cell & Gene Meeting on the Mesa (October 2017)Conference23 slidesOct 5, 2017
Rodman & Renshaw Global Investment Conference 2017Conference39 slidesSeptember 2017
Biotech Showcase 2017Conference46 slidesJan 9, 2017
Investor Presentation (November 2016)Investor deck20 slidesNovember 2016
Technical Presentation (October 2013)Technical19 slidesOctober 2013
Cappello US Investor Conference (January 2013)Conference30 slidesJanuary 2013
Cowen US Investor Showcase (January 2013)Conference13 slidesJanuary 2013
Investor Presentation (November 2012)Investor deck26 slidesNovember 2012
Investor Presentation (October 2012)Investor deck29 slidesOctober 2012
Investor Presentation (November 2011)Investor deck54 slidesNov 18, 2011
Benitec — Non-Deal Roadshow (April 2007)Roadshow27 slidesApr 27, 2007
Benitec — Shareholder Meeting (November 2006)Shareholder meeting15 slidesNov 30, 2006
Benitec — AusBiotech National Conference 2006Conference21 slidesNov 27, 2006
Benitec — Investor Presentation (October 2005)Investor deck49 slidesOct 21, 2005
Benitec — Investor Presentation (February 2004)Investor deck19 slidesFeb 20, 2004
Benitec — Investor Presentation (January 2004)Investor deck15 slidesJanuary 2004

Open Decks

Financings

RaiseDate
Public offering of common stock
Update: US$13.5 a share · Leerink Partners +2
Dealers: Leerink Partners (co-lead), TD Cowen (co-lead), Evercore ISI (co-lead)
Use of proceeds: Continued development of product candidate programs, working capital and general corporate purposes
Nov 6, 2025
Registered direct offering of common stock
Update: US$13.5 a share · Leerink Partners +2
Dealers: Leerink Partners, TD Cowen, Evercore ISI
Buyers: Suvretta Capital (1,481,481 shares of common stock)
Use of proceeds: Continued development of product candidate programs, working capital and general corporate purposes
Nov 6, 2025
Public offering of common stock or pre-funded warrants
Announced: US$13 a share · Leerink Partners +2
Dealers: Leerink Partners (co-lead), TD Cowen (co-lead), Citizens Capital Markets
Use of proceeds: Continued development of product candidate programs, working capital and general corporate purposes
Mar 25, 2025
Registered direct offering of common stock
Announced: US$13 a share
Buyers: Suvretta Capital (900,000 shares of common stock)
Use of proceeds: Continued development of product candidate programs, working capital and general corporate purposes
Mar 25, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue075.0K73.0K59.0K102.0K12.2M4.40M195.9K
Cost of revenue474.0K160.0K
Gross profit3.95M35.9K
Research and development23.4M18.3M15.6M12.8M11.3M7.02M3.00M4.57M3.73M4.07M
Selling, general and administrative4.72M5.35M
Operating income-51.2M-41.8M-22.5M-19.1M-17.9M-13.6M-8.28M2.58M-8.73M-15.9M
Depreciation and amortization58.0K66.0K87.0K136.0K167.0K231.0K190.0K158.0K195.0K217.0K
EBITDA-51.1M-41.7M-22.4M-18.9M-17.7M-13.4M-8.09M2.74M-8.53M-15.7M
Interest expense00
Income before tax-45.3M-37.2M-21.0M-19.0M-17.4M7.91M-299.0K169.0K-8.55M-3.35M
Income tax0-4.21M-10.3M
Net income-45.5M-37.9M-21.8M-19.6M-18.2M-13.9M-8.27M2.61M-12.3M-5.60M
Earnings per share, basic-0.98-1.05-1.22-14.12-37.88-3.23-8.103.05-74.68-40.72
Earnings per share, diluted-0.98-1.05-1.22-14.12-37.88-3.23-8.103.05

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents180.0M97.7M50.9M2.48M4.06M19.8M9.80M15.7M16.2M17.4M
Short-term investments22.0K76.8K
Receivables4.27M3.49M
Inventory0-65.1K
Current assets181.7M98.5M51.7M3.73M4.82M20.6M10.8M18.8M21.0M22.2M
Property, plant and equipment178.0K131.0K179.0K87.0K222.0K375.0K374.0K470.0K319.0K445.0K
Goodwill00
Total assets182.6M99.6M52.2M4.46M5.97M21.4M11.6M19.2M21.4M22.7M
Accounts payable426.1K133.7K
Current liabilities5.34M1.80M4.92M3.98M2.53M1.37M1.14M2.64M2.56M864.5K
Long-term debt00
Total debt00
Total liabilities5.61M2.30M4.96M4.26M3.09M1.37M1.35M2.64M2.61M891.4K
Shareholders' equity177.0M97.3M47.2M202.0K2.88M20.0M10.2M16.6M13.8M21.6M
Shares outstanding34.4M26.3M10.1M1.67M480.7K8.17M1.11M856.8K165.1K137.6K

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-16.5M-23.6M-19.4M-18.0M-15.9M-12.8M-7.54M4.79M-9.79M-8.30M
Capital spending-105.0K-18.0K-179.0K-1.00K-13.0K-221.0K-95.0K-404.0K-61.0K-131.4K
Free cash flow-16.6M-23.6M-19.6M-18.0M-15.9M-13.1M-7.63M4.39M-8.61M-8.44M
Cash from investing-105.0K-18.0K-179.0K-1.00K-13.0K-221.0K-94.0K-400.0K-147.0K-302.0K
Cash from financing99.0M70.5M68.0M16.0M22.5M1.77M8.51M7.94M
Dividends paid00
Share buybacks8.82M8.07M
Change in cash82.2M46.9M48.4M-1.59M-15.7M9.97M-1.29M-855.0K

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 13, 2026Quarterly reportSEC
8-K · Current reportNov 13, 2026ResultsSEC
8-K · Current reportOct 28, 2026Current reportSEC
DEFA14A · Additional proxy materialOct 20, 2026Meeting noticeSEC
DEF 14A · Proxy statementOct 20, 2026Meeting noticeSEC
8-K · Current reportOct 5, 2026Current reportSEC
8-K · Current reportSep 30, 2026Current reportSEC
8-K · Current reportSep 24, 2026Current reportSEC
EFFECT · Notice that a registration is effectiveSep 22, 2026Other filingsSEC
S-3 · Registration statementSep 14, 2026Offer documentSEC
Show 200 filings
FilingDateTypeFiled with
10-K · Annual reportSep 14, 2026Annual reportSEC
8-K · Current reportSep 14, 2026ResultsSEC
4 · Change in ownershipJun 30, 2026Insider tradeSEC
8-K · Current reportMay 29, 2026Management or board changeSEC
4 · Change in ownershipMay 28, 2026Insider tradeSEC
3 · Initial statement of ownershipMay 28, 2026Insider tradeSEC
10-Q · Quarterly reportMay 14, 2026Quarterly reportSEC
8-K · Current reportMay 14, 2026ResultsSEC
UPLOAD · Letter from the SECApr 3, 2026Other filingsSEC
CORRESP · Letter to the SECMar 20, 2026Other filingsSEC
10-K/A · Annual report, amendedMar 20, 2026Annual reportSEC
UPLOAD · Letter from the SECFeb 24, 2026Other filingsSEC
8-K · Current reportFeb 12, 2026ResultsSEC
10-Q · Quarterly reportFeb 12, 2026Quarterly reportSEC
EFFECT · Notice that a registration is effectiveFeb 11, 2026Other filingsSEC
424B3 · ProspectusFeb 10, 2026Offer documentSEC
CORRESP · Letter to the SECFeb 6, 2026Other filingsSEC
UPLOAD · Letter from the SECFeb 6, 2026Other filingsSEC
S-3 · Registration statementJan 30, 2026Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 29, 2026Big-stake noticeSEC
4 · Change in ownershipJan 26, 2026Insider tradeSEC
4 · Change in ownershipDec 29, 2025Insider tradeSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedDec 8, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeDec 3, 2025Big-stake noticeSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
8-K · Current reportDec 2, 2025Meeting outcomeSEC
4 · Change in ownershipNov 20, 2025Insider tradeSEC
4 · Change in ownershipNov 20, 2025Insider tradeSEC
4 · Change in ownershipNov 20, 2025Insider tradeSEC
8-K · Current reportNov 14, 2025ResultsSEC
10-Q · Quarterly reportNov 14, 2025Quarterly reportSEC
DEFA14A · Additional proxy materialNov 12, 2025Meeting noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedNov 10, 2025Big-stake noticeSEC
4 · Change in ownershipNov 10, 2025Insider tradeSEC
4 · Change in ownershipNov 7, 2025Insider tradeSEC
3 · Initial statement of ownershipNov 7, 2025Insider tradeSEC
8-K · Current reportNov 6, 2025Material contractSEC
424B5 · ProspectusNov 6, 2025Offer documentSEC
424B5 · ProspectusNov 5, 2025Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 4, 2025Big-stake noticeSEC
8-K · Current reportNov 3, 2025Management or board changeSEC
DEFA14A · Additional proxy materialOct 14, 2025Meeting noticeSEC
DEF 14A · Proxy statementOct 14, 2025Meeting noticeSEC
EFFECT · Notice that a registration is effectiveSep 30, 2025Other filingsSEC
CORRESP · Letter to the SECSep 26, 2025Other filingsSEC
UPLOAD · Letter from the SECSep 25, 2025Other filingsSEC
S-3 · Registration statementSep 22, 2025Offer documentSEC
8-K · Current reportSep 22, 2025ResultsSEC
10-K · Annual reportSep 22, 2025Annual reportSEC
8-K · Current reportSep 12, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
8-K · Current reportJul 9, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveJun 3, 2025Other filingsSEC
424B3 · ProspectusJun 2, 2025Offer documentSEC
CORRESP · Letter to the SECMay 29, 2025Other filingsSEC
UPLOAD · Letter from the SECMay 29, 2025Other filingsSEC
S-3 · Registration statementMay 23, 2025Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 14, 2025Big-stake noticeSEC
8-K · Current reportMay 14, 2025ResultsSEC
10-Q · Quarterly reportMay 14, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 9, 2025Big-stake noticeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
8-K · Current reportMar 28, 2025Current reportSEC
4 · Change in ownershipMar 28, 2025Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 28, 2025Big-stake noticeSEC
8-K · Current reportMar 27, 2025Material contractSEC
424B5 · ProspectusMar 26, 2025Offer documentSEC
8-K · Current reportMar 26, 2025Material contractSEC
8-K · Current reportMar 20, 2025Current reportSEC
8-K · Current reportMar 19, 2025Current reportSEC
4 · Change in ownershipMar 13, 2025Insider tradeSEC
4 · Change in ownershipMar 3, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
8-K · Current reportFeb 14, 2025ResultsSEC
10-Q · Quarterly reportFeb 14, 2025Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 27, 2025Big-stake noticeSEC
3 · Initial statement of ownershipJan 3, 2025Insider tradeSEC
8-K/A · Current report, amendedDec 31, 2024Management or board changeSEC
4 · Change in ownershipDec 26, 2024Insider tradeSEC
8-K · Current reportDec 13, 2024Management or board changeSEC
4 · Change in ownershipDec 11, 2024Insider tradeSEC
4 · Change in ownershipDec 11, 2024Insider tradeSEC
4 · Change in ownershipDec 11, 2024Insider tradeSEC
4 · Change in ownershipDec 11, 2024Insider tradeSEC
4 · Change in ownershipDec 11, 2024Insider tradeSEC
4 · Change in ownershipDec 11, 2024Insider tradeSEC
8-K · Current reportDec 10, 2024Current reportSEC
8-K · Current reportDec 6, 2024Meeting outcomeSEC
SC 13G/A · Big-stake notice, amendedDec 6, 2024Big-stake noticeSEC
4 · Change in ownershipDec 5, 2024Insider tradeSEC
4 · Change in ownershipNov 21, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedNov 18, 2024Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 14, 2024Big-stake noticeSEC
8-K · Current reportNov 14, 2024ResultsSEC
DEFA14A · Additional proxy materialNov 14, 2024Meeting noticeSEC
10-Q · Quarterly reportNov 14, 2024Quarterly reportSEC
8-K · Current reportNov 14, 2024Management or board changeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 13, 2024Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveNov 13, 2024Other filingsSEC
CORRESP · Letter to the SECNov 12, 2024Other filingsSEC
UPLOAD · Letter from the SECNov 8, 2024Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 7, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 6, 2024Big-stake noticeSEC
S-3 · Registration statementNov 1, 2024Offer documentSEC
SC 13G/A · Big-stake notice, amendedOct 25, 2024Big-stake noticeSEC
DEF 14A · Proxy statementOct 23, 2024Meeting noticeSEC
DEFA14A · Additional proxy materialOct 22, 2024Meeting noticeSEC
8-K · Current reportOct 15, 2024Current reportSEC
424B5 · ProspectusOct 15, 2024Offer documentSEC
424B5 · ProspectusOct 11, 2024Offer documentSEC
PRE 14A · Preliminary proxy statementOct 11, 2024Meeting noticeSEC
8-K · Current reportOct 11, 2024Material contractSEC
8-K · Current reportOct 8, 2024Current reportSEC
S-8 · Registration statement for employee plansOct 1, 2024Offer documentSEC
SC 13D/A · Big-stake notice, amendedSep 30, 2024Big-stake noticeSEC
4 · Change in ownershipSep 30, 2024Insider tradeSEC
8-K · Current reportSep 26, 2024ResultsSEC
10-K · Annual reportSep 26, 2024Annual reportSEC
8-K · Current reportSep 4, 2024Management or board changeSEC
DEF 14A · Proxy statementJul 29, 2024Meeting noticeSEC
PRE 14A · Preliminary proxy statementJul 19, 2024Meeting noticeSEC
8-K · Current reportJul 15, 2024Current reportSEC
3 · Initial statement of ownershipJul 8, 2024Insider tradeSEC
8-K · Current reportJul 1, 2024Management or board changeSEC
424B3 · ProspectusMay 29, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveMay 29, 2024Other filingsSEC
CORRESP · Letter to the SECMay 23, 2024Other filingsSEC
UPLOAD · Letter from the SECMay 22, 2024Other filingsSEC
S-1 · Registration statementMay 15, 2024Offer documentSEC
8-K · Current reportMay 13, 2024ResultsSEC
10-Q · Quarterly reportMay 13, 2024Quarterly reportSEC
3 · Initial statement of ownershipMay 2, 2024Insider tradeSEC
SC 13D · Big-stake noticeApr 29, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeApr 29, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeApr 29, 2024Big-stake noticeSEC
DApr 25, 2024Other filingsSEC
8-K · Current reportApr 18, 2024Material contractSEC
8-K · Current reportApr 18, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedApr 11, 2024Big-stake noticeSEC
8-K · Current reportMar 8, 2024Management or board changeSEC
4 · Change in ownershipMar 8, 2024Insider tradeSEC
4 · Change in ownershipMar 8, 2024Insider tradeSEC
EFFECT · Notice that a registration is effectiveMar 6, 2024Other filingsSEC
CORRESP · Letter to the SECMar 1, 2024Other filingsSEC
UPLOAD · Letter from the SECFeb 28, 2024Other filingsSEC
DEL AMFeb 26, 2024Other filingsSEC
S-3 · Registration statementFeb 23, 2024Offer documentSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
8-K · Current reportFeb 13, 2024ResultsSEC
10-Q · Quarterly reportFeb 13, 2024Quarterly reportSEC
S-8 · Registration statement for employee plansDec 22, 2023Offer documentSEC
SC 13G/A · Big-stake notice, amendedDec 11, 2023Big-stake noticeSEC
4 · Change in ownershipDec 7, 2023Insider tradeSEC
4 · Change in ownershipDec 7, 2023Insider tradeSEC
4 · Change in ownershipDec 7, 2023Insider tradeSEC
8-K · Current reportDec 7, 2023Management or board changeSEC
8-K · Current reportNov 30, 2023Current reportSEC
8-K · Current reportNov 13, 2023ResultsSEC
10-Q · Quarterly reportNov 13, 2023Quarterly reportSEC
DEFA14A · Additional proxy materialOct 20, 2023Meeting noticeSEC
DEF 14A · Proxy statementOct 20, 2023Meeting noticeSEC
8-K · Current reportOct 16, 2023Management or board changeSEC
8-K · Current reportSep 28, 2023Current reportSEC
8-K · Current reportSep 21, 2023ResultsSEC
10-K · Annual reportSep 21, 2023Annual reportSEC
8-K · Current reportSep 18, 2023Management or board changeSEC
SC 13G/A · Big-stake notice, amendedSep 11, 2023Big-stake noticeSEC
SC 13G · Big-stake noticeAug 25, 2023Big-stake noticeSEC
SC 13G · Big-stake noticeAug 21, 2023Big-stake noticeSEC
SC 13G · Big-stake noticeAug 18, 2023Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedAug 18, 2023Big-stake noticeSEC
4 · Change in ownershipAug 14, 2023Insider tradeSEC
4 · Change in ownershipAug 14, 2023Insider tradeSEC
8-K · Current reportAug 11, 2023Material contractSEC
8-K · Current reportAug 10, 2023Current reportSEC
424B4 · ProspectusAug 10, 2023Offer documentSEC
EFFECT · Notice that a registration is effectiveAug 9, 2023Other filingsSEC
S-1/A · Registration statement, amendedAug 7, 2023Offer documentSEC
CORRESP · Letter to the SECAug 3, 2023Other filingsSEC

This page holds 200 of 336 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Benitec Biopharma Inc.’s releases · as of Sep 30, 2026

Common shares
34,889,313
Fully diluted
34,889,313

Fully diluted

LineSharesAs of
Common shares34,889,313Sep 30, 2026

Share count over time

CountShares
Sep 30, 202634,889,313
Sep 30, 202634,889,313

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Montanova Capital, LLC11.5M33.1%US$115MSep 30, 2026
Franklin Templeton2.41M6.9%US$22.4MSep 30, 2026
Janus Henderson2.35M6.7%US$23.4MSep 30, 2026
Adage Capital Partners Gp, L.L.C.2.12M6.1%US$21.2MSep 30, 2026
Ra Capital Management, L.P.1.85M5.3%US$18.5MSep 30, 2026
Nantahala Capital Management, LLC1.68M4.8%US$16.8MSep 30, 2026
BlackRock1.43M4.1%US$14.3MSep 30, 2026
Vanguard1.39M4.0%US$13.9MSep 30, 2026
Infinitum Asset Management, LLC1.26M3.6%US$12.6MSep 30, 2026
Simplify Asset Management Inc.1M2.9%US$10MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Millennium760K2.2%US$7.6MSep 30, 2026
Alyeska Investment Group, L.P.750K2.2%US$7.5MSep 30, 2026
Geode Capital666K1.9%US$6.66MSep 30, 2026
Balyasny Asset Management L.P.650K1.9%US$6.5MSep 30, 2026
Silverarc Capital Management, LLC443K1.3%US$4.43MSep 30, 2026
State Street428K1.2%US$4.28MSep 30, 2026
Ameriprise393K1.1%US$3.93MSep 30, 2026
Citadel271K0.78%US$2.71MSep 30, 2026
MYDA Advisors LLC260K0.75%US$2.6MSep 30, 2026
Schonfeld Strategic Advisors LLC236K0.68%US$2.36MSep 30, 2026
Goldman Sachs194K0.55%US$1.94MSep 30, 2026
Northern Trust192K0.55%US$1.92MSep 30, 2026
AWM Investment Company, Inc.188K0.54%US$1.88MSep 30, 2026
UBS120K0.34%US$1.2MSep 30, 2026
Walleye Capital LLC77,9840.22%US$780KSep 30, 2026
Wellington71,1960.20%US$712KSep 30, 2026
Schwab70,9180.20%US$709KSep 30, 2026
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.67,4850.19%US$675KSep 30, 2026
Lion Point Capital, LP62,0000.18%US$620KSep 30, 2026
BNY59,8610.17%US$599KSep 30, 2026
Bank of America52,5800.15%US$526KSep 30, 2026
Atom Investors LP48,2900.14%US$483KSep 30, 2026
Cantor Fitzgerald, L. P.46,6590.13%US$467KSep 30, 2026
Morgan Stanley42,8930.12%US$429KSep 30, 2026
Nuveen33,4030.10%US$334KSep 30, 2026
Woodline Partners LP29,1180.08%US$291KSep 30, 2026
XTX Topco Ltd28,1470.08%US$281KSep 30, 2026
Rhumbline Advisers27,7950.08%US$278KSep 30, 2026
Quadrature Capital Ltd26,3020.08%US$263KSep 30, 2026
AQR Capital Management LLC25,0510.07%US$251KSep 30, 2026
CPP Investments23,7000.07%US$237KSep 30, 2026
Russell Investments Group, Ltd.22,3140.06%US$223KSep 30, 2026
Point72 Asset Management, L.P.22,2110.06%US$222KSep 30, 2026
American Century20,5310.06%US$205KSep 30, 2026
T. Rowe Price18,5280.05%US$186KSep 30, 2026
DWS18,1610.05%US$182KSep 30, 2026
Martingale Asset Management L P16,1500.05%US$162KSep 30, 2026
MetLife Investment Management, LLC15,4240.04%US$154KSep 30, 2026
Creative Planning15,3270.04%US$153KSep 30, 2026
Prudential Financial Inc14,8080.04%US$148KSep 30, 2026

This page holds 50 of 87 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Simplify Health Care ETF1.01M2.9%US$13.5MJun 30, 2026
Franklin Biotechnology Discovery Fund995K2.9%US$11.7MJul 31, 2026
Vanguard Total Stock Market Index Fund650K1.9%US$8.69MJun 30, 2026
iShares Russell 2000 ETF534K1.5%US$7.14MJun 30, 2026
Franklin Small Cap Growth Fund358K1.0%US$4.19MJul 31, 2026
Vanguard Extended Market Index Fund282K0.81%US$3.77MJun 30, 2026
Fidelity Small Cap Index Fund233K0.67%US$2.73MJul 31, 2026
iShares Russell 2000 Value ETF188K0.54%US$2.52MJun 30, 2026
Fidelity Extended Market Index Fund131K0.38%US$1.51MMay 31, 2026
Vanguard Russell 2000 Index Fund99,9690.29%US$1.16MMay 31, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
iShares Micro-Cap ETF71,5270.21%US$957KJun 30, 2026
Schwab Small-Cap Index Fund51,7450.15%US$606KJul 31, 2026
Fidelity Total Market Index Fund42,2980.12%US$489KMay 31, 2026
Master Small Cap Index Series41,8530.12%US$560KJun 30, 2026
Fidelity Series Total Market Index Fund38,6250.11%US$447KMay 31, 2026
Nuveen Small Cap Blend Index Fund28,3390.08%US$332KJul 31, 2026
Fidelity Small Cap Value Index Fund28,1020.08%US$376KJun 30, 2026
Fidelity Nasdaq Composite Index Fund24,1900.07%US$280KMay 31, 2026
EQ/2000 Managed Volatility Portfolio21,2710.06%US$285KJun 30, 2026
Schwab Total Stock Market Index Fund19,0000.05%US$222KJul 31, 2026
Global X Genomics & Biotechnology ETF18,3500.05%US$212KMay 31, 2026
Vanguard Russell 2000 Growth Index Fund18,0300.05%US$208KMay 31, 2026
Fidelity ZERO Total Market Index Fund13,0000.04%US$152KJul 31, 2026
Vanguard Institutional Total Stock Market Index Fund12,0140.03%US$161KJun 30, 2026
iShares Russell 2000 Growth ETF11,6990.03%US$157KJun 30, 2026
LVIP State Street Small-Cap Index Fund11,3000.03%US$151KJun 30, 2026
Vanguard Balanced Index Fund11,0780.03%US$148KJun 30, 2026
Small Cap Index Fund11,0640.03%US$148KJun 30, 2026
U.S. Small Cap Equity Fund10,2080.03%US$137KJun 30, 2026
Global X Russell 2000 ETF10,1910.03%US$119KJul 31, 2026
MetLife Russell 2000 Index Portfolio9,4580.03%US$127KJun 30, 2026
Goldman Sachs Absolute Return Tracker Fund9,0010.03%US$120KJun 30, 2026
Fidelity ZERO Extended Market Index Fund8,9640.03%US$105KJul 31, 2026
Small Cap Index Fund8,0250.02%US$92,769May 31, 2026
Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF7,7300.02%US$89,359May 31, 2026
State Street Small/Mid Cap Equity Index Portfolio6,6000.02%US$88,308Jun 30, 2026
Small-Cap Index Portfolio5,6640.02%US$75,784Jun 30, 2026
1290 VT Micro Cap Portfolio4,8170.01%US$64,451Jun 30, 2026
NVIT Small Cap Index Fund4,7790.01%US$63,943Jun 30, 2026
ATM Small Cap Managed Volatility Portfolio4,3170.01%US$57,761Jun 30, 2026
Fidelity Flex Small Cap Index Fund4,0270.01%US$47,156Jul 31, 2026
Victory Extended Market Index Fund3,8640.01%US$45,247Jul 31, 2026
Small Cap Index Trust3,6660.01%US$49,051Jun 30, 2026
Bridge Builder Small/Mid Cap Growth Fund3,5520.01%US$47,526Jun 30, 2026
DWS Small Cap Index VIP3,347<0.01%US$44,783Jun 30, 2026
T. Rowe Price Small-Cap Index Fund3,251<0.01%US$43,498Jun 30, 2026
1290 VT Small Cap Value Portfolio2,974<0.01%US$39,792Jun 30, 2026
Voya RussellTM Small Cap Index Portfolio2,763<0.01%US$36,969Jun 30, 2026
BlackRock Small Cap Index V.I. Fund2,721<0.01%US$36,407Jun 30, 2026
SA Small Cap Index Portfolio2,496<0.01%US$29,228Jul 31, 2026

This page holds 50 of 88 holders. Open Shareholders

Big stakes

StakeStakeSharesDateFiling
Montanova Capital, LLC44.10%17.8MNov 7, 2025Schedule 13D
Franklin Resources Inc10.60%3.75MDec 31, 2025Schedule 13G
Janus Henderson Group PLC9.99%3.38MNov 28, 2025Schedule 13G
Ra Capital Management, L.P.5.50%1.85MNov 7, 2025Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Aaron Cowen
Other companies: Veradermics, Incorporated (Director · Since at least Feb 4, 2026)
Director · Since at least Sep 26, 2024
David Friedman
Other companies: Veradermics, Incorporated (Board Member · Since at least Nov 5, 2026)
Director · Since at least Mar 25, 2025
Edward SmithDirector · Since at least Nov 5, 2026
Jerel BanksChief Executive Officer & Chairman of the Board · Since at least Apr 15, 2020
J. Kevin BuchiDirector · Since at least Jun 30, 2026
Kishen MehtaDirector · Since at least Mar 25, 2025
Megan BostonChief Financial Officer, Director · Since at least Sep 23, 2025
Peter FrancisDirector · Since at least Nov 5, 2026
Peter FrancisDirector · Since at least Apr 15, 2020
Sharon MatesDirector · Since at least Nov 3, 2025
All 11 people
PersonSeat
Sophie MukadamChief Operating Officer · Since at least Jan 1, 2025

Open People

Log in to ask 6ix AI your own questions about Benitec Biopharma Inc.